Newsroom
Featured Post
On The Path of Gratitude: East German Climbers in North Korea’s Diamond Mountains
Filter
The consequence of patents on BRCA genes
Guest post by Sue Friedman On April 15, 2013, the U.S. Supreme Court heard arguments on whether Myriad Genetics’ patents on the BRCA genes, which are associated with hereditary breast and ovarian cancer, should be upheld. This case culminates a four-year legal...